We've always represented West Virginians statewide. Our new Charleston office gives Kanawha County and surrounding communities a more convenient place to meet our team.
This guide explains legal options for families in Star City and Monongalia County who believe a baby developed necrotizing enterocolitis after exposure to contaminated or unsafe infant formula. NEC is a serious medical condition that can lead to hospitalization and long-term complications, and when product defects, contamination, or labeling failures are suspected, families may have grounds to pursue mass tort claims. Stephen New & Associates represents clients across West Virginia, including Beckley and Star City, and this guide outlines what to expect, how claims are organized, and initial steps to protect evidence and medical records while exploring potential recovery.
Pursuing a legal claim after an infant develops NEC linked to formula can offer several important benefits to families. A responsible claim can secure compensation for medical costs, ongoing care needs, and other financial burdens while seeking accountability from manufacturers or distributors. In addition to potential financial recovery, coordinated legal action can help ensure thorough investigation into product safety, encourage improvements to labeling and manufacturing, and provide families with consistent legal guidance throughout complex proceedings. Mass tort approaches can combine resources to address shared scientific issues and streamline the handling of many similar claims.
Necrotizing enterocolitis is a serious intestinal condition that primarily affects newborns and can cause inflammation, infection, and tissue damage in the bowel. Symptoms may include feeding intolerance, abdominal distension, bloody stools, lethargy, and sudden clinical decline, often requiring urgent hospitalization, surgery, or intensive care. Medical teams use imaging, bloodwork, and clinical signs to diagnose NEC, and the condition may lead to long-term digestive, growth, or developmental concerns depending on severity. When NEC follows exposure to a contaminated or defective infant formula, families may investigate whether the product contributed to the condition and whether legal remedies are available.
A mass tort is a legal process used when many individuals are harmed by the same product, drug, or practice and similar factual and scientific questions arise across cases. Unlike a class action, a mass tort preserves each person’s individual claim while coordinating discovery, expert work, and certain pretrial proceedings to handle common issues more efficiently. This approach can allow shared resources for scientific study, while still enabling families to seek individualized compensation for medical care, long-term needs, and emotional impact. Mass tort procedures often involve centralized filings, pooled evidence development, and negotiation or litigation tailored to both common and unique aspects of each claim.
A class action consolidates many similar claims into a single lawsuit where one or more people represent a larger group with common legal issues, and any recovery is distributed under court oversight unless members opt out. Class actions can be appropriate when the injuries and legal questions are substantially identical across the group, but they can limit individual control over settlements and the amount each person can recover. In NEC or infant formula cases, plaintiffs and counsel will evaluate whether a class action or a mass tort structure better serves the needs of affected families, taking into account the variety of medical outcomes, individualized damages, and the desire for case-by-case allocations of compensation.
Product liability refers to legal claims that a consumer product was defective in design, manufacturing, or labeling and that the defect caused injury. In the context of infant formula, claims may allege contamination during manufacturing, unsafe formulations, inadequate safety testing, or failure to provide proper storage or preparation warnings. Liability can attach to manufacturers, packagers, distributors, or retailers depending on the chain of commerce and the nature of the defect. Successful product liability claims typically rely on medical records, product documentation, testing data, and expert analysis to show a connection between the product and the injury sustained by the infant.
Keep complete hospital and pediatric records related to the infant’s NEC diagnosis and treatment, including emergency room notes, imaging studies, laboratory results, surgery reports, and discharge summaries, because these documents form the foundation of any claim. If possible, request copies of records early and maintain organized digital and physical copies, and provide feeding logs and any documentation from caregivers that show timelines or symptom progression. Early preservation of records helps counsel review the case promptly and reduces the risk that vital information will be lost or delayed during an investigation.
Record details about the type of formula, how it was prepared, dates and times of feedings, changes in feeding patterns, and the onset and progression of symptoms, because these notes can help establish temporal connections between formula use and the child’s illness. If packaging, batch numbers, or preparation containers remain, keep those items in case testing or inspection becomes relevant to the claim. Detailed caregiving notes provide context for medical records and can be valuable when counsel and medical reviewers evaluate causation and the sequence of events leading to diagnosis and treatment.
Do not throw away formula containers, packaging, unused product, or any feeding equipment until instructed by counsel or investigators, since those items can be tested and examined to identify contamination, manufacturing irregularities, or labeling defects. If items must be stored, place them in a cool, dry location and photograph packaging and labels, including lot numbers and expiration dates, to document their condition. Preserving physical evidence and photographic records supports scientific review and strengthens the factual basis for any claim.
When many families report similar injuries linked to the same formula product or batch, a coordinated mass tort approach can be appropriate because it concentrates resources for common investigations and scientific review. Consolidation helps manage complex discovery, allows pooling of testing and consulting resources, and can yield a more comprehensive picture of manufacturing or distribution issues. Families retain their individual claims while benefiting from coordinated handling of shared factual questions and joint efforts to obtain documents and testing from manufacturers and regulatory agencies.
Cases involving microbiological contamination, formulation defects, or multifactorial causes require coordinated scientific analysis that is often best handled through a mass tort framework where specialists and testing resources can be shared across many claims. A coordinated approach allows counsel to secure bulk testing, consult with medical reviewers, and seek access to internal manufacturing and quality control records needed to prove systemic problems. When causation depends on laboratory data and product tracing, collective action helps ensure a thorough and methodical examination of the evidence.
If a family’s situation appears isolated, with clear documentation tying a single defective item to an injury and no indication of a broader pattern, pursuing an individual product liability claim may be the most direct path to recovery. An individual claim can focus on gathering the necessary medical records, evidence of the specific product involved, and expert analysis tailored to the single case without the added procedural complexity of coordinated mass proceedings. Counsel will evaluate whether the facts and available evidence support an individualized filing and whether other similar reports exist that could change the recommended approach.
When product identification is clear and testing or inspection unequivocally links the specific item used to contamination or a defect, a targeted claim can efficiently pursue compensation based on those concrete findings. Counsel will still collect hospital records, product packaging, and any lab results, but the investigation may proceed on a narrower evidentiary track focused on the identified item and its chain of custody. This path can resolve more quickly when the scientific connection is straightforward and the responsible party can be definitively identified.
Contamination during manufacturing, packaging, or storage can introduce bacteria or other pathogens into powdered or liquid infant formula, creating a direct risk of infection and intestinal injury for vulnerable infants, and families often seek investigation when blood or culture results suggest a link. When multiple reports identify the same contamination source, legal claims focus on how the contamination occurred and whether proper quality control, testing, and recalls were timely and effective.
Manufacturing practices that fail to meet accepted safety standards, including inadequate sanitation, faulty equipment, or improper handling of ingredients, can lead to defects that harm infants and prompt legal liability for manufacturers and others in the supply chain. Claims may allege that the company did not maintain appropriate controls, rejected contaminated batches, or failed to investigate and remediate known issues, and documentation of factory procedures and quality control records plays a central role in these allegations.
Inadequate labeling, unclear preparation instructions, or failure to warn about vulnerabilities in certain populations can increase the risk of harm and form the basis for legal claims when caregivers followed directions but an infant still developed NEC. Legal reviews examine whether warnings were sufficient, whether instructions reduced contamination risks, and whether the product’s labeling accurately reflected safe handling and storage recommendations to protect newborns.
Families in Star City and across West Virginia turn to Stephen New & Associates because the firm concentrates on serious injury and product liability matters that require careful medical and factual review. The attorneys and staff assist clients in collecting hospital records, preserving physical evidence, and coordinating with independent reviewers to assess whether a product may have contributed to an infant’s NEC. The firm has handled a wide range of matters including birth injuries, medical malpractice, and mass torts, and it aims to provide consistent communication, compassionate handling of sensitive medical issues, and practical guidance about available legal options and potential outcomes.
Necrotizing enterocolitis is a severe intestinal injury that primarily affects newborns and premature infants, characterized by inflammation and, in serious cases, necrosis of bowel tissue. Medical teams diagnose NEC based on symptoms, imaging, laboratory tests, and clinical presentation, and while multiple factors can contribute to its development, outbreaks or clusters of cases associated with a particular formula product can raise concerns about contamination or manufacturing defects. When caregivers and clinicians observe temporal links between formula use and the onset of NEC symptoms, that information becomes important for legal evaluation and further medical and laboratory investigation. To explore a possible link between formula and NEC, counsel and medical reviewers will collect hospital records, microbiology results, feeding histories, and any remaining product packaging or batch information. Laboratory testing, epidemiological data, and internal manufacturing records can help establish whether contamination or defects were present and whether they plausibly contributed to the infant’s illness. These combined medical and product data points form the basis for a legal claim and inform decisions about whether a mass tort or individual product liability action is appropriate.
Determining whether a child’s NEC supports a mass tort or product liability claim begins with a careful review of medical records, feeding timelines, and any available product information such as lot numbers or packaging photographs. If many similar reports arise involving the same product or batch, coordinated mass tort handling may be appropriate because it concentrates investigative resources and addresses common scientific questions. In contrast, an individual product liability claim may be suitable when a single identifiable product can be tied to the injury with clear documentation and testing that supports causation. Counsel will also consider available laboratory results, hospital testing, and whether regulatory notices or recalls exist for the product. The presence of recurring patterns across multiple infants, shared batch numbers, or internal manufacturing records suggesting lapses can point toward a mass tort approach, while isolated incidents with strong individual evidence may be litigated as separate claims. The initial evaluation focuses on assembling the factual and medical record needed to recommend the most effective procedural path.
Preserve complete hospital and pediatric records, including admission notes, imaging reports, surgical records, discharge summaries, laboratory and culture results, and any documentation of treatments or follow-up care, because these records are central to establishing diagnosis, severity, and care needs. Keep feeding logs, notes from caregivers about symptom onset and progression, and any communications with medical providers, as these items help piece together timelines and potential links to product use. Request copies of records early to ensure nothing is lost over time, and store digital backups to avoid accidental loss. If any product packaging, unused formula containers, preparation equipment, or feeding bottles remain, do not discard them; instead photograph the items, including lot numbers and expiration dates, and store them securely. Photograph and retain receipts, delivery records, or any correspondence related to the product purchase or storage. These physical and documentary items may prove essential for laboratory testing, product tracing, and establishing a chain of custody during legal proceedings, and early preservation strengthens the ability to investigate causation.
Class actions and mass torts are both mechanisms for handling multiple similar claims, but they differ in important ways that affect how formula-related cases proceed. A class action combines many claims into one suit where a representative plaintiff and counsel act on behalf of the entire class, often resulting in a single settlement or judgment that is allocated across class members under court supervision. A mass tort, by contrast, coordinates many individual cases that share common factual or scientific questions while preserving each claimant’s right to seek individualized compensation and present unique damages and medical histories. In NEC formula scenarios, mass torts are commonly used when victims share common exposure or product-related issues but have varied clinical outcomes and individualized damages, because this approach allows joint handling of discovery and expert work while respecting each family’s distinct circumstances. Counsel will evaluate the medical evidence, number of affected families, and the nature of the injuries to decide which structure better balances efficiency with individualized recovery opportunities.
Potential compensation in NEC formula cases can include reimbursement for past and future medical expenses related to hospitalization, surgeries, intensive care, medications, and ongoing therapies that the child requires. Families may also seek recovery for incidental costs such as travel and lodging for medical care, lost income for caregivers who must provide care, and the cost of long-term supports if the child faces ongoing digestive, developmental, or growth challenges. Damages intended to address pain and suffering, emotional distress, and diminished quality of life may also be pursued depending on the circumstances and applicable law. The particular types and amounts of compensation depend on the severity of the injury, the documented care needs, prognostic medical opinions, and the legal theory of liability pursued. Each case is evaluated on its own facts, and settlements or judgments account for both economic and non-economic harms. Counsel works with families to document present and future needs, obtain supporting medical opinions, and pursue recovery that reflects the full impact of the child’s illness.
The timeline for resolving an NEC-related claim varies considerably based on the complexity of the scientific and medical issues, the volume of discovery required, whether many claims are coordinated in a mass tort, and whether defendants engage in settlement discussions or litigate to trial. Simple individual claims with clear evidence may be resolved more quickly, sometimes within months to a few years, while complex mass torts involving extensive testing, multiple parties, and coordinated proceedings can take several years to reach resolution. The process typically involves document production, expert reviews, motion practice, and possible bellwether trials or settlement negotiations. Families should expect ongoing communication about likely timelines and key milestones, and counsel will advise about interim needs such as obtaining medical care, preserving records, and securing expert analysis. While speed is important, thorough investigation and careful development of medical and scientific evidence often determine outcomes, and plaintiffs may need to balance the desire for prompt resolution with the need for a well-supported claim.
Many firms handling mass tort and product liability claims operate on a contingency fee basis, which means that families do not pay attorney fees unless their case results in a recovery, and that the firm typically advances litigation-related costs while the matter proceeds. This arrangement helps make legal representation accessible when families face substantial medical bills and caregiving burdens, and it aligns counsel’s interests with pursuing a meaningful recovery. Specific fee structures and cost arrangements vary, so it is important to discuss and confirm how fees, costs, and any potential deductions will be handled during the initial consultation. If a recovery is achieved, fees and costs are generally deducted from the final award or settlement under the agreed terms, and families receive the remainder. In the absence of recovery, clients typically are not responsible for attorneys’ fees, though they should confirm whether any expenses advanced by counsel would need to be repaid under particular circumstances. Transparent discussion of financial terms at the outset helps families make informed decisions without unexpected obligations.
A product recall can strengthen a family’s claim by providing formal recognition that a product posed a safety risk, which can support allegations that the product was defective or that the manufacturer failed to address known hazards promptly. Recalls and safety alerts can yield important documentary evidence, including recall notices, internal communications, and regulatory findings that may be used to demonstrate notice of a problem and the company’s response. Counsel will review recall details, timing, and scope to assess how they relate to a particular child’s exposure and injury. However, not every recall automatically proves liability for every injured person, and the specifics of exposure, timing, and documented harm still matter. Recalls often trigger additional investigations and testing that can uncover further evidence, and families should preserve any product packaging, lot numbers, and purchase records to connect the recalled item to the child’s use. If a recall is present, it usually becomes a key point of inquiry during case development and can influence strategy and negotiations with defendants.
Establishing causation between a formula product and NEC requires demonstrating a plausible link supported by medical records, laboratory data, and, when available, product testing that ties the specific item or batch to contamination or defects. Counsel and medical reviewers examine the timing of feedings and symptom onset, microbiological culture results, imaging and surgical findings, and any epidemiological data showing similar cases tied to the same product. Scientific analysis, including laboratory testing of remaining product or environmental samples, can be essential to demonstrate that exposure plausibly caused or substantially contributed to the infant’s condition. Because NEC can have multiple contributing factors, building a persuasive causation case often involves comprehensive documentation and expert interpretation of clinical and laboratory results. Coordinated review of hospital records, feeding histories, and product evidence helps identify patterns and rule out alternative causes, and the combination of clinical correlation and product testing strengthens the factual foundation needed to pursue legal claims successfully.
To begin evaluating a potential NEC formula claim, contact a law office experienced in serious personal injury and product liability matters and prepare to provide a detailed timeline and copies of all relevant medical records, including hospital admissions, test results, and discharge summaries. Gather any product packaging, receipts, photographs, feeding logs, or other items that document the product used and how it was prepared and stored, because those items aid in the initial review and help counsel determine whether further testing or investigation is warranted. A preliminary consultation typically clarifies whether the facts warrant a more in-depth inquiry. During the initial phase, counsel will review the records, discuss likely evidence needs, explain procedural options such as individual claims or coordinated mass tort filings, and outline the steps to preserve evidence and pursue discovery. Families should ask about fees, timelines, and what to expect during investigation, and they should keep copies of all medical and product documentation to speed the evaluation process and support potential claims.
Explore our complete legal services